platelet aggregation inhibitor
CHEBI:CHEBI_50427
Definition
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
Alternative Names
- platelet aggregation inhibitors
Treatment Applications
-
platelet-type bleeding disorder 12View Disease →
DOID:0111058
Drug Classification
-
hematologic agentView Class →
CHEBI:50248
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:50427
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- oboInOwl#hasOBONamespace
- chebi_ontology
- oboInOwl#id
- CHEBI:50427
- core#notation
- CHEBI:50427
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_90848
- has_treatment
- http://purl.obolibrary.org/obo/DOID_5844
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_109669
- owl#someValuesFrom
- t324287
- owl#annotatedSource
- t234437